The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 497-500

  White, K E ^a   Jonsson, K B ^a   Carn, G ^a   Hampson, G ^a   Spector, T D ^a   Mannstadt, M ^a   Lorenz Depiereux, B ^a   Miyauchi, A ^a   In Myung Yang, ^a   Ljunggren, O ^a   Meitinger, T ^a   Strom, T M ^a   Juppner H ^a   Econs, M J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; MESSENGER RNA; PHOSPHATE; POLYPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; VITAMIN D RESISTANT RICKETS;

ANIMALIA;

EID: 17744395066     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.2.7408     Document Type: Article

References (13)

1. Tumor-induced osteomalacia-unveiling a new hormone
2. Autosomal dominant hypophosphatemic rickets/osteomalacia: Clinical characterization of a novel renal phosphate wasting disorder
3. Vitamin D metabolite levels in oncogenic osteomalacia
4. Mendelian hypophosphatemias
5. Autosomal dominant hypophosphatemic rickets (ADHR) is associated with mutations in a gene encoding a novel member of the fibroblast growth factor family (FGF-23)
6. Hemangiopericytoma-induced osteomalacia: Tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity
7. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: A case report
8. Phosphate uptake inhibitory activity in serum of patients with oncogenic osteomalacia
9. Brief report: Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia
10. Candidate 56 and 58 kda protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia
11. Further characterisation of the phosphate regulating factor in oncogenic osteomalacia and mutation analysis of the PHEX gene in tumor cell DNA
12. Defining the roles of parathyroid hormone-related protein in normal physiology
13. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets